NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea · Delayed Price · Currency is KRW 555.00
-32.00 (-5.45%)
At close: Feb 27, 2026
NeoImmuneTech Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -29,657 | -40,883 | -53,405 | -60,406 | -52,482 | -30,456 |
Depreciation & Amortization | 3,959 | 3,959 | 3,210 | 2,802 | 1,873 | 987.98 |
Loss (Gain) From Sale of Assets | 346.87 | 346.87 | 1.89 | 12.78 | 108.48 | - |
Asset Writedown & Restructuring Costs | 526.92 | 526.92 | - | - | - | - |
Loss (Gain) From Sale of Investments | - | - | - | - | - | -140.72 |
Stock-Based Compensation | 1,522 | 1,522 | 5,893 | 5,631 | 9,204 | 3,048 |
Provision & Write-off of Bad Debts | 1,009 | 1,009 | 225.98 | - | - | - |
Other Operating Activities | -4,602 | -5,352 | -2,138 | 2,909 | -271.91 | 1,513 |
Change in Accounts Receivable | -20.37 | -20.37 | - | - | - | - |
Change in Other Net Operating Assets | -3,206 | -3,206 | -3,548 | 6,646 | 7,682 | -3,858 |
Operating Cash Flow | -30,122 | -42,098 | -49,761 | -42,405 | -33,887 | -28,906 |
Capital Expenditures | -1,138 | -1,670 | -791.39 | -2,477 | -2,710 | -1,087 |
Sale of Property, Plant & Equipment | 181.93 | 1.36 | - | 6.98 | - | - |
Sale (Purchase) of Intangibles | -2,804 | - | - | - | - | - |
Investment in Securities | -13,368 | -13,368 | - | - | - | 5,676 |
Other Investing Activities | 2,313 | 2,566 | 2,715 | 836.55 | -1,119 | -424.97 |
Investing Cash Flow | -14,668 | -12,470 | 2,087 | -3,150 | -3,828 | 4,164 |
Long-Term Debt Issued | - | 13,368 | - | - | - | - |
Long-Term Debt Repaid | - | -1,278 | -1,178 | -1,036 | -713.73 | -292.15 |
Net Debt Issued (Repaid) | 413.49 | 12,089 | -1,178 | -1,036 | -713.73 | -292.15 |
Issuance of Common Stock | 46,984 | - | 41.26 | 402.56 | 115,763 | 261.12 |
Other Financing Activities | 9.99 | - | - | - | 0 | - |
Financing Cash Flow | 47,407 | 12,089 | -1,136 | -633.32 | 115,049 | -31.03 |
Foreign Exchange Rate Adjustments | -1,461 | -1,716 | -97.54 | -3,075 | -682.37 | -0.53 |
Miscellaneous Cash Flow Adjustments | - | - | -0 | -0 | - | - |
Net Cash Flow | 1,156 | -44,195 | -48,908 | -49,263 | 76,652 | -24,774 |
Free Cash Flow | -31,260 | -43,768 | -50,552 | -44,881 | -36,596 | -29,993 |
Free Cash Flow Margin | -33153.69% | -25688.01% | - | - | - | - |
Free Cash Flow Per Share | -97.74 | -442.70 | -511.40 | -454.42 | -384.18 | -362.92 |
Cash Interest Paid | 249.15 | 238.45 | 220.99 | 253.77 | 226.7 | 171.3 |
Cash Income Tax Paid | 22.82 | 113.01 | 133.62 | 58.2 | 32.91 | 9.86 |
Levered Free Cash Flow | -14,279 | -23,921 | -38,500 | -28,855 | -25,579 | -21,631 |
Unlevered Free Cash Flow | -13,826 | -23,468 | -38,360 | -28,692 | -25,442 | -21,515 |
Change in Working Capital | -3,226 | -3,226 | -3,548 | 6,646 | 7,682 | -3,858 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.